1259
中文   |   English 手机浏览
wenguang wang Specially appointed Associate Researcher for Jiangsu Province's Double Innovation Doctoral Program Wang Wenguang Group, China Pharmaceutical University
Wang Wenguang, Ph.D. in Double Creation in Jiangsu Province, recipient of one hundred outstanding doctoral theses in Jiangsu Province, and specially appointed associate researcher. From 2015 to 2021, I pursued a Master's and Doctoral degree in Pharmacy at Nanjing University. I visited the University of California, Riverside in the United States from 2019 to 2020. In September 2021, joined the Vaccine Center of the School of Basic Medicine and Clinical Pharmacy at China Pharmaceutical University. Publish papers in internationally renowned SCI journals such as Nature Biomedical Engineering and Nature Communications. The research results have been extensively cited by Science, Chemical Society Reviews, Cell Host&Microbe, JACS, and others. Educational experience 2015-2021 Nanjing University Master's and Doctoral Joint Program Supervisors: Professors Wu Jinhui and Hu Yiqiao 2019-2020 University of California, Riverside Mentor: Prof Ian Wheeldon
Research More >
Main research direction 1. Research and development of therapeutic tumor vaccines, including in situ tumor vaccines and mRNA vaccines, as well as research and transformation of novel tumor vaccines and adjuvant co delivery carriers. 2. Research and development of novel nucleic acid delivery systems for gene therapy and in vivo CAR cell therapy.
News More >